HLAクラスIリガンドの大部分は,プロテアソームによって生成されたペプチドである

Juliane Liepe¹, Fabio Marino^2,3, John Sidney⁴

¹Centre for Integrative Systems Biology and Bioinformatics, Department of Life Sciences, Imperial College London, London SW7 2AZ, UK. michele.mishto@charite.de j.liepe@imperial.ac.uk.

Science (New York, N.Y.)

|November 16, 2016

まとめ

プロテアソームによって生成されたペプチドは豊富で,HLAクラスIエピトープの重要な部分を構成する. この発見は免疫生物学に影響を与え癌の免疫療法とワクチン開発の新たな道を開きます

科学分野:

免疫学
プロテアソーム生物学
T細胞エピトープの表示

背景:

プロテアゾームは,ヒト白血球抗原 (HLA) クラスI分子によって提示されるエピトープを生成し,CD8+ T細胞応答を開始するために不可欠です.
以前は,プロテアソームによって生成されたスパライスされたエピトープは,免疫系において稀な発生と考えられていた.

研究の目的:

HLAクラスI免疫ペプチドーム内のプロテアソーム生成のペプチドの有病率と特性を調査する.
これらのスプライスされたエピトープの免疫生物学への影響と医療における潜在的な応用を決定する.

主な方法:

実験技術とバイオインフォマティクス分析の組み合わせを用いた.
堅固さを確保するために複数の細胞タイプで検証された結果

主要な成果:

プロテアソームによって生成されたペプチドは,HLAクラスI免疫ペプチドームの相当な部分を占め,その多様性の3分の1と4分の1を占める.
独特で特徴的な結合抗原を特定しました

結論:

プロテアソーム触媒ペプチドスプライシングは稀な現象ではなく広範囲に広がる現象です
これらの発見は,免疫生物学と自己免疫性の理解に重要な意味を持ち,ワクチンとがん免疫療法の新たなエピトープ源を示しています.

さらに関連する動画

08:27

Detection of Human Leukocyte Antigen Biomarkers in Breast Cancer Utilizing Label-free Biosensor Technology

Published on: March 24, 2015

15.4K

07:59

A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes

Published on: March 25, 2014

15.7K

関連する概念動画

02:18

The Proteasome

10.4K

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...

10.4K

01:13

The Proteasome

1.9K

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...

1.9K

01:19

Translocation of Proteins into the Mitochondria

13.6K

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...

13.6K

01:31

Antigen Processing Pathways

2.8K

MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...

2.8K

01:17

The Proteasome Structure

2.0K

The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...

2.0K

01:26

Antigens Involved in Adaptive Immunity

1.8K

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...